Cancer and Metastasis Reviews

, Volume 13, Issue 3–4, pp 285–302 | Cite as

Chemoprevention of colon cancer by dietary fatty acids

  • Bandaru S. Reddy


During the last two decades, substantial progress has been made in the understanding of the relationship between the dietary constituents and development of colon cancer in man. Unlike studies of cancer among smokers and nonsmokers, nutritional epidemiologic studies are confronted with the inherent difficulty of assessing reasonably precise exposures. The lack of consistency between international correlation studies and case-control studies does not necessarily negate a dietary etiology of colon cancer because these inconsistencies may have arisen, at least in part, from methodological limitations. Some of these deficiencies in epidemiological studies of diet and cancer have been corrected; recent case-control studies demonstrated that high dietary fat is a risk factor for colon cancer development and that an overall increase in intake of foods high in fiber might decrease the risk for colon cancer. The results of epidemiologic studies may be assumed to present conservative estimates of the true risk for cancer associated with diet. The populations with high incidence of colon cancer are characterized by high consumption of dietary fat, which may be a risk factor in the absence of factors that are protective, such as whole-grain cereals and of other high-fiber. Laboratory animal model studies have shown that certain dietary lipids and fibers influence tumorigenesis in the colon. The data of metabolic epidemiological and laboratory animal model studies are sufficiently convincing with recpect to enhancement of colon cancer by type of fat and protection by certain dietary fibers.

Key words

chemoprevention colon cancer dietary fat omega-3 fatty acids prostaglandins bile acids 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Wynder EL, Gori GB: Contribution of the environment to cancer incidence: an epidemiologic exercise. J Natl Cancer Inst 58: 825–832, 1977Google Scholar
  2. 2.
    Doll R, Peto R: The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 66: 1191–1308, 1981Google Scholar
  3. 3.
    Committee on Diet and Health, Food and Nutrition Board, Diet and Health, National Research Council, National Academy of Sciences, Washington, DC, 1989, p 593Google Scholar
  4. 4.
    Reddy BS: Animal experimental evidence on macronutrients and cancer. In: Micozzi MS, Moon TE (eds) Macronutrients Investigating Their Role in Cancer. Marcel Dekker Inc., New York, 1992, pp 33–54Google Scholar
  5. 5.
    Reddy BS: Diet and colon cancer: Evidence from human and animal model studies. In: Reddy BS, Cohen LA (eds) Diet, Nutrition, and Cancer: A Critical Evaluation, Vol. 1. CRC Press, Boca Raton, Florida, 1986, pp 47–65Google Scholar
  6. 6.
    Wynder EL, Kajitani T, Ishikawa S, Dodo H, Takano A: Environmental factors in cancer of colon and rectum. Cancer 23: 1210–1220, 1969Google Scholar
  7. 7.
    World Health Statistics Annual, World Health Organization, Geneva, Switzerland, 1980Google Scholar
  8. 8.
    Jain M, Cook GM, Davis FG, Grace MG, Howe GR, Miller AB: A case-control study of diet and colorectal cancer. Int J Cancer 26: 757–768, 1980Google Scholar
  9. 9.
    Miller AB, Howe GR, Jain M: Food items and food groups as risk factors in a case-control study of diet and colon cancer. Int J Cancer 32: 155–166, 1983Google Scholar
  10. 10.
    Graham S, Marshall J, Hanghey B, Mittleman A, Swanson M, Zielexny M, Byers T, Wilkinson G, West D: Am J Epidemiol 128: 490–503, 1988Google Scholar
  11. 11.
    Reddy BS, Hedges AT, Laakso K, Wynder EL: Metabolic epidemiology of large bowel cancer: Fecal bulk and constituents of high-risk North American and low-risk Finnish population. Cancer 42: 2832–2838, 1978Google Scholar
  12. 12.
    Willet WC, Stampfer MJ, Colditz GA, Rosner BA, Speizer FE: Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. New Eng J Med 323: 1664–1672, 1990Google Scholar
  13. 13.
    Dyerberg J, Bang HO, Stofferson E, Moncada S, Vani JR: Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis. Lancet 2: 177–179, 1978Google Scholar
  14. 14.
    Stansby ME: Fatty acids in fish. In: Simopoulos AP, Kifer RR, Martin RE (eds) Health Effects of Polyunsaturated Fatty Acids in Seafoods. Academic Press, New York, 1986, pp 389–401Google Scholar
  15. 15.
    Dyerberg J, Bjerregaare P: Mortality from ischaemic heart disease and cerebrovascular disease in Greenland. In: Land WEM (ed) Proceedings of the AOCS Short Course on Polyunsaturated Fatty Acids and Eicosanoids, Champaign, IL. American Oil Chemists' Society, 1987, pp 2–8Google Scholar
  16. 16.
    Bang HO, Dyerberg J, Hjorne N: The composition of food consumed by Greenland Eskimos. Acta Med Scand 200: 69–73, 1976Google Scholar
  17. 17.
    Hirai A, Terano T, Saito H, Tamura Y, Yoshida S: Clinical and epidemiological studies of eicosapentaenoic acid in Japan. In: Lands WEM (ed) Proceedings of the AOCS Short Course on Polyunsaturated Fatty Acids and Eicosanoids. Champaign, IL. American Oil Chemists' Society, 1987, pp 9–24Google Scholar
  18. 18.
    Neilsen NH, Hansen JPH: Breast cancer in Greenland: selected epidemiological, clinical and histological features. J Cancer Res Clin Oncol 98: 287–299, 1980Google Scholar
  19. 19.
    Blot WJ, Lainer A, Fraumeni JF Jr, Bender TR: Cancer mortality among Alaskan natives, 1960-69. J Natl Cancer Inst 55: 546–554, 1975Google Scholar
  20. 20.
    Waterhouse J, Muir C, Correa P, Powell J: Cancer Incidence in Five Continents, Vol. 3. International Agency for Research on Cancer, Lyon, France, 1976Google Scholar
  21. 21.
    Berg JW: Can nutrition explain the pattern of international epidemiology of hormone-dependent cancers? Cancer Res 35: 3345–3350, 1975Google Scholar
  22. 22.
    Mishina T, Watanabe H, Araki N, Nakao M: Epidemiological study of prostatic cancer by matched-pair analysis. Prostate 6: 423–436, 1985Google Scholar
  23. 23.
    Shamsuddin AK:In vivo induction of colon cancer, dose and animal species. In: Autrup H, Williams GM (eds) Experimental Colon Carcinogenesis. CRC Press, Boca Raton, 1983, pp 51–62Google Scholar
  24. 24.
    Reddy BS, Tanaka T, Simi B: Effect of different levels of dietary trans fat or corn oil on azoxymethane-induced colon carcinogenesis in F344 rats. J Natl Cancer Inst 75: 791–798, 1985Google Scholar
  25. 25.
    Diamond L, O'Brien TG, Baird WM: Tumor promoters and the mechanism of tumor promotion. Adv Cancer Res 32: 1–74, 1980Google Scholar
  26. 26.
    Maskens AP: Confirmation of the two-step nature of chemical carcinogenesis in the rat colon adenocarcinoma model. Cancer Res 41: 1240–1245, 1981Google Scholar
  27. 27.
    Nigro ND, Singh DV, Campbell RL, Pak MS: Effect of dietary beef fat on intestinal tumor formation by azoxymethane in rats. J Natl Cancer Inst 54: 439–442, 1975Google Scholar
  28. 28.
    Broitman SA, Vitale JJ, Vavrousek-Jakuba E, Gottlieb LS: Polyunsaturated fat, cholesterol and large bowel tumorigenesis. Cancer 40: 2455–2463, 1977Google Scholar
  29. 29.
    Howarth AE, Pihl E: High-fat diet promotes and causes distal shift of experimental rat colonic cancer - beer and alcohol do not. Nutr Cancer 6: 229–235, 1985Google Scholar
  30. 30.
    Reddy BS, Mangat S, Weisburger JH, Wynder EL: Effect of high-risk diets for colon carcinogenesis on intestinal mucosal and bacterial β-glucuronidase activity in F344 rats. Cancer Res 37: 3533–3536, 1977Google Scholar
  31. 31.
    Reddy BS, Watanabe K, Weisburger JH: Effect of high-fat diet on colon carcinogenesis in F344 rats treated with 1,2-dimethylhydrazine, methylazoxymethanol acetate and methylnitrosourea. Cancer Res 37: 4156–4159, 1977Google Scholar
  32. 32.
    Reddy BS, Ohmori T: Effect of intestinal microflora and dietary fat on 3,2′-dimethyl-4-aminobiphenyl-induced colon carcinogenesis in F344 rats. Cancer Res 41: 1363–1367, 1981Google Scholar
  33. 33.
    Reddy BS, Narisawa T, Vukusich D, Weisburger JH, Wynder EL: Effect of quality and quantity of dietary fat and dimethylhydrazine in colon carcinogenesis in rats. Proc Soc Exp Biol Med 151: 237–239, 1976Google Scholar
  34. 34.
    Nutter RL, Kettering JD, Apprecio RM, Weeks DA, Gridley DS: Effects of dietary fat and protein on DMH-induced tumor development and immune responses. Nutr Cancer 13: 141–152, 1990Google Scholar
  35. 35.
    Sakaguchi M, Hiramatsu Y, Takada H, Yamamura M, Hioki K, Sato K, Yamamoto M: Effect of dietary unsaturated and saturated fats on azoxymethane-induced colon carcinogenesis in rats. Cancer Res 44: 1472–1477, 1984Google Scholar
  36. 36.
    Pence BC, Buddingh F: Inhibition of dietary fat-promoted colon carcinogenesis in rats by supplemental calcium or vitamin D3. Carcinogenesis 9: 187–190, 1988Google Scholar
  37. 37.
    Nauss KM, Locniscar M, Newberne PM: Effect of alterations in the quality and quantity of dietary fat on 1,2-dimethylhydrazine-induced colon tumorigenesis in rats. Cancer Res 43: 4083–4090, 1983Google Scholar
  38. 38.
    Bull AW, Soullier BK, Wilson PS, Haydon MT, Nigro ND: Promotion of azoxymethane-induced intestinal cancer by high-fat diets in rats. Cancer Res 39: 4956–4959, 1979Google Scholar
  39. 39.
    Reddy BS, Maruyama H: Effect of different levels of dietary corn oil and lard during the initiation phase of colon carcinogenesis in F344 rats. J Natl Cancer Inst 77: 815–822, 1986Google Scholar
  40. 40.
    Reddy BS, Burill C, Rigotty J: Effect of diets high in omega-3 and omega-6 fatty acids on the initiation and postinitiation stages of colon carcinogenesis. Cancer Res 51: 487–491, 1991Google Scholar
  41. 41.
    Reddy BS, Maruyama H: Effect of dietary fish oil on azoxymethane-induced colon carcinogenesis in male F344 rats. Cancer Res 46: 3367–3370, 1986Google Scholar
  42. 42.
    Reddy BS, Maeura Y: Tumor promotion by dietary fat in azoxymethane induced colon carcinogenesis in female F344 rats: Influence of amount and source of dietary fat. J Natl Cancer Inst 72: 745–750, 1984Google Scholar
  43. 43.
    Rao CV, Reddy BS: Modulating effect of amount and types of dietary fat on ornithine decarboxylase, tyrosine protein kinase and prostaglandins production during colon carcinogenesis. Carcinogenesis 14: 1327–1333, 1993Google Scholar
  44. 44.
    Nelson RL, Tanure JC, Andrianopoulos G, Souza G, Lands WEM: A comparison of dietary fish oil and corn oil in experimental colorectal carcinogenesis. Nutr Cancer 11: 215–220, 1988Google Scholar
  45. 45.
    Deschner EE, Lytle JJ, Wong G, Ruperto JF, Newmark HL: The effect of dietary omega-3 fatty acids (fish oil) on azoxymethane-induced focal areas of dysplasia and colon tumor incidence. Cancer 66: 2350–2356, 1990Google Scholar
  46. 46.
    Minoura T, Takata T, Sakaguchi M, Hideho T, Yamamura M, Hioka K, Yamamoto M: Effect of dietary eicosapentaenoic acid on azoxymethane-induced colon carcinogenesis in rats. Cancer Res 48: 4790–4794, 1988Google Scholar
  47. 47.
    Hirosa M, Masuda A, Ito N, Kamano K, Okuyama H: Effects of dietary perilla oil, soybean oil and safflower oil on 7,12-dimethylbenz[a]anthracene (DMAB) and 1,2-dimethylhydrazine (DMH)-induced mammary gland and colon carcinogenesis in female SD rats. Carcinogenesis 11: 731–735, 1990Google Scholar
  48. 48.
    Hogan ML, Shamsuddin AM: Large intestinal carcinogenesis. 1. promotional effect of dietary fatty acid isomers in the rat model. J Natl Cancer Inst 73: 1293–1296, 1984Google Scholar
  49. 49.
    Lipkin M: Biomarkers of increased susceptibility to gastrointestinal cancer: new application to studies of cancer prevention in human subjects. Cancer Res 48: 235–245, 1988Google Scholar
  50. 50.
    Deschner EE, Maskens AP: Significance of labeling index and labeling distribution as kinetic parameters in colorectal mucosa of cancer patients and DMH treated animals. Cancer 50: 1136–1141, 1982Google Scholar
  51. 51.
    Takano S, Matsushima M, Erturk E, Bryan GT: Early induction of rat colonic epithelial ornithine and S-adenosyl-L-methionine decarboxylase activities by N-methyl-N′-nitro-N-nitrosoguanidine or bile salts. Cancer Res 41: 624–628, 1981Google Scholar
  52. 52.
    Rozhin J, Wilson PS, Bull AW, Nigro ND: Ornithine decarboxylase activity in the rat and human colon. Cancer Res 44: 3226–3230, 1984Google Scholar
  53. 53.
    Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R, Soltoff S: Oncogenes and signal transduction. Cell 64: 281–302, 1991Google Scholar
  54. 54.
    Reddy BS, Sugie S: Effect of different levels of omega-3 and omega-6 fatty acids on azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Res 48: 6642–6647, 1988Google Scholar
  55. 55.
    Narisawa T, Takahashi M, Niwa M, Fukaura Y, Wakizaka A: Involvement of prostaglandin E2 in bile acid caused promotion of colon carcinogenesis and anti-promotion by the cyclooxygenase inhibitor indomethacin. Gann 78: 791–798, 1985Google Scholar
  56. 56.
    Craven PA, DeRubertis FR: Role of activation of protein kinase C in the stimulation of colonic epithelia proliferation by unsaturated fatty acids. Gastroenterology 95: 676–685, 1988Google Scholar
  57. 57.
    Reddy BS, Mangat S, Sheinfil A, Weisburger JH, Wynder EL: Effect of type and amount of dietary fat and 1,2-dimethylhydrazine on biliary bile acids, fecal bile acids and neutral sterols in rats. Cancer Res 37: 2132–2137, 1977Google Scholar
  58. 58.
    DeRubertis FR, Craven PA, Saito R: Bile salt stimulation of colonic epithelial proliferation: evidence for the involvement of lipoxygenase products. J Clin Invest 74: 1614–1624, 1984Google Scholar
  59. 59.
    Nakadate T, Yamamoto S, Ishii M, Kato R: Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity by phospholipase A2 inhibitors and lipoxygenase inhibitor. Cancer Res 42: 2841–2845, 1982Google Scholar
  60. 60.
    Verma AK, Ashendel CL, Boutwell RK: Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins, and tumor promotion caused by 12-O-tetradecanoyl-phorbol-13-acetate. Cancer Res 40: 308–315, 1980Google Scholar
  61. 61.
    Kumar PS, Roy SJ, Tokumo K, Reddy BS: Effect of different levels of calorie restriction on azoxymethane-induced colon carcinogenesis in male F344 rats. Cancer Res 50: 5761–5766, 1990Google Scholar
  62. 62.
    Craven PA, Pfanstial J, DeRubertis FR: Role of activation of protein kinase C in the stimulation of colonic epithelial proliferation and reactive oxygen formation by bile salts. J Clin Invest 79: 532–541, 1987Google Scholar
  63. 63.
    Heffetz D, Bushkin I, Dror R, Zick Y: The insulinomimetic agents H2O2 and vanadate stimulate protein tyrosine phosphorylation in intact cells. J Biol Chem 265: 2896–2902, 1990Google Scholar
  64. 64.
    DeRubertis FR, Craven PA: Relationship of bile salt stimulation of colonic epithelial phospholipid turnover and proliferative activity: role of activation of protein kinase C. Prev Med 16: 572–579, 1987Google Scholar
  65. 65.
    Narisawa T, Takahashi M, Kotanagi H, Kusaka H, Yamazaki Y, Koyamo H, Fukawara Y, Nishizawa Y, Kolsugeri M, Isoda Y, Hirano J, Tanidu N: Inhibitory effect of dietary perilla oil rich in the n-polyunsaturated fatty acid α-linoleic acid on colon carcinogenesis in rats. Jpn J Cancer Res 82: 1089–1096, 1991Google Scholar
  66. 66.
    Narisawa T, Satoh M,Sano M, Takahashi T: Inhibition of initiation and promotion on N-methylnitrosourea-induced colon carcinogenesis in rats by non-steroid anti-inflammatory agent indomethacin. Carcinogenesis 4: 1225–1227, 1983Google Scholar
  67. 67.
    Pollard M, Luckert PH: Effect of piroxicam on primary intestinal tumors induced in rats by N-methylnitrosourea. Cancer Lett 25: 117–121, 1984Google Scholar
  68. 68.
    Reddy BS, Maruyama H, Kelloff G: Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal anti-inflammatory drug, during different stages of rat colon tumor development. Cancer Res 47: 5340–5346, 1987Google Scholar
  69. 69.
    Kulkarni N, Zang E, Kelloff G, Reddy BS: Effect of chemopreventive agents, piroxicam and D,L-α-difluoromethylornithine on intermediate biomarkers of colon carcinogenesis. Carcinogenesis 13: 995–1000, 1992Google Scholar
  70. 70.
    Culp BR, Titus BJ, Lands WE: Inhibition of prostaglandin biosynthesis by eicosapentaenoic acid. Prostaglandins Med 3: 269–278, 1979Google Scholar
  71. 71.
    Weber P: Fish oil fatty acids and cardiovascular function: epidemiology and biochemical mechanisms. Biochem Soc Trans 18: 1045–1049, 1990Google Scholar
  72. 72.
    Nishizuka Y, Takai Y, Kishimoto A, Kikkawa U, Kaibuchi K: Phospholipid turnover in hormone actions. Recent Prog Horm Res 40: 301–345, 1984Google Scholar
  73. 73.
    Fitzer CJ, O'Brian C-A, Guillem JG, Weinstein BI: The regulation of protein kinase C by chenodeoxycholate, deoxycholate and several structurally related bile acids. Carcinogenesis 8: 217–220, 1987Google Scholar
  74. 74.
    Birt DF, Kris ES, Choe M, Pelling JC: Dietary energy and fat effects on tumor promotion. Cancer Res 52: 2035S-2039S, 1992Google Scholar
  75. 75.
    Donnelly TE, Birt DF, Sittlev R, Anderson CL, Choe M, Julius AD: Benzoyl peroxide activation of protein kinase C activity in epidermal cell membranes. Carcinogenesis 8: 1867–1870, 1987Google Scholar
  76. 76.
    Marotomi M, Guillem JG, LoGerfo P, Weinstein IB: Production of diacylglycerol, an activator of protein kinase C, by human intestinal microflora. Cancer Res 50: 3595–3599, 1990Google Scholar
  77. 77.
    Friedman E, Isaksson P, Rafter J, Marian B, Winawer S, Newmark H: Fecal diglycerides as selective endogenous mitogens for permalignant and malignant human colonic epithelial cells. Cancer Res 49: 544–548, 1989Google Scholar
  78. 78.
    Wargovich MJ, Eng VWS, Newmark HL, Bruce WR: Calcium ameliorates the toxic effect of deoxycholic acid on colonic epithelium. Carcinogenesis 4: 1236–1240, 1983Google Scholar
  79. 79.
    Smart RC, Huang MT, Conney AH: Sn-1,2-diacylglycerols mimic the effect of 12-O-tetradecanoyl phorbol-13-acetatein vivo by inducting biochemical changes associated with tumor promotion in mouse epidermis. Carcinogenesis 7: 1865–1870, 1986Google Scholar
  80. 80.
    Bos JL: Ras oncogenes in human cancer: A review. Cancer Res 49: 4682–4689, 1989Google Scholar
  81. 81.
    Lacal JC, Tronick SR: The ras oncogene. In: Reddy EP, Shalka AM, Curran T (eds) The Oncogene Handbook. Elsevier, New York, 1988, pp 535–550Google Scholar
  82. 82.
    Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, Van der Eb AJ, Vogelstein B: Prevalence of ras mutations in human colorectal cancers. Nature 327: 293–297, 1987Google Scholar
  83. 83.
    Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AMM, Bos JL: Genetic alterations during colorectal tumor development. N Engl J Med 319: 525–532, 1988Google Scholar
  84. 84.
    Jacoby RF, Uor X, Teng BB, Davidson NO, Brasitus TA: Mutations in the K-ras oncogene induced by 1,2-dimethylhydrazine in preneoplastic and neoplastic rat colonic mucosa. J Clin Invest 87: 624–630, 1991Google Scholar
  85. 85.
    Jacoby RF, Alexander RJ, Raicht RF, Brasitus TA: K-ras oncogene mutations in rat colon tumors induced by N-methyl-N-nitrosourea. Carcinogenesis 13: 45–49, 1992Google Scholar
  86. 86.
    Feramisco JR, Gross M, Kamata T, Rasenberg M, Sweet RW: Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of the quiescent cells. Cell 38: 109–117, 1984Google Scholar
  87. 87.
    Rudney H, Sexton RC: Regulation of cholesterol biosynthesis. Annual Rev Nutr 6: 245–271, 1986Google Scholar
  88. 88.
    Goldstein JL, Brown MS: Regulation of the mevalonate pathway. Nature 343: 425–430, 1990Google Scholar
  89. 89.
    Casey PJ, Solsky PA, Der CJ, Bus JE: p21 ras is modified by a farnesyl isoprenoid. Proc Natl Acad Sci USA 86: 8323–8327, 1989Google Scholar
  90. 90.
    Wolda SL, Glomset JA: Evidence for modification of lamin B by a product of mevalonic acid. J Biol Chem 263: 5997–6000, 1988Google Scholar
  91. 91.
    Cox AD, Channing JD: The ras/cholestrol connection: implications for ras oncogenicity. Critical Reviews in Oncogenesis 3: 365–400, 1992Google Scholar
  92. 92.
    Hancock JF, Magee AI, Childs JE, Marshall CJ: All ras proteins are polyisoprenylated but only some are palmitoylated. Cell 57: 1167–1177, 1989Google Scholar
  93. 93.
    Brown MS, Goldstein JL: Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. J Lipid Res 21: 505–517, 1980Google Scholar
  94. 94.
    Sebti SM, Thalcevic GT, Jani JP: Lovastatin, a cholestrol biosynthesis inhibitor, inhibits the growth of human H-ras oncogene transformed cells in nude mice. Cancer Communications 3: 141–147, 1991Google Scholar
  95. 95.
    Lacal JC, Moscat J, Aaronson SA: Novel source of 1,2-diacylglycerol elevated in cells transformed by Ha-ras oncogene. Nature 330: 269–272, 1987Google Scholar
  96. 96.
    Goldfarb S, Pitot HC: The regulation of β-hydroxy-β-methylglutaryl coenzyme A reductase in morris Hepatomas 5123C, 7800, and 9618A. Cancer Res 31: 1879–1882, 1971Google Scholar
  97. 97.
    Bartram HP, Gostner A, Scheppach W, Reddy BS, Rao CV, Dusel G, Richter F, Richter A, Kasper H: Effects of fish oil on rectal cell proliferation, mucosal fatty acids, and prostaglandin E2 release in healthy subjects. Gastroenterology 105: 1317–1322, 1993Google Scholar
  98. 98.
    Anti M, Marra G, Armelao F. Bartoli GM, Ficarelli R, Percesepe A, Vitis I, Miggiano G: Effect of omega-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer. Gastroenterology 103: 883–891, 1992Google Scholar
  99. 99.
    The Surgeon General's Report on Nutrition and Health, U.S. Department of Health and Human Services, Public Health Service, DHHS (PHS) Publication No. 88-50210, U.S. Government Printing Office, Washington, DC, 1988Google Scholar
  100. 100.
    National Research Council, Diet and Health, Implications for Reducing Chronic Disease Risk, National Academy Press, Washington, DC, 1989Google Scholar

Copyright information

© Kluwer Academic Publishers 1994

Authors and Affiliations

  • Bandaru S. Reddy
    • 1
  1. 1.Division of Nutritional CarcinogenesisAmerican Health FoundationValhallaUSA

Personalised recommendations